Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
Designing Peptide Mimetics for the Treatment of Multiple Sclerosis
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
273-282
Author(s):
J. Matsoukas, V. Apostolopoulos and T. Mavromoustakos
An Approach to the Rational Design of Opioid Receptor Ligands Non-narcotic k-Opioid Receptor Ligand KT-95 Free from Euphoria and or Dysphoria
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
1-25
Author(s):
Ken Kanematsu and Takeshi Sagara
alpha Conotoxins Nicotinic Acetylcholine Receptor Antagonists as Pharmacological Tools and Potential Drug Leads
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
327-344
Author(s):
Julie L. Dutton and David J. Craik
Expanding our Understanding of Polyglutamine Disease Through Transgenic Mice
Journal:
Current Genomics
Volume:
2
Page:
27-39
Author(s):
Jennifer D. Davidson and Harry T. Orr
Toxicokinetics in Drug Development: An Overview of Toxicokinetic Application in the Development of PNU-101017, an Anxiolytic Drug Candidate
Journal:
Current Drug Metabolism
Volume:
1
Page:
243-254
Author(s):
W. Z. Zhong, M. G. Williams and D. G. Branstetter
Analysis of Clinical Pharmacology Research Publication in Doping and Anti-Doping: A Scientometric Study
Journal:
Current Drug Therapy
Volume:
19
Page:
1-8
Author(s):
Vikas Katiyara, Hemasri Velmurugan, Himanshu Nirmal Chandu, Muthathal Subramanian, Pugazhenthan Thangaraju*, Sajitha Venkatesan and Eswaran Thangaraju